Table of Contents:

1 Report Prologue
2 Introduction
2.1 Definition
2.2 Scope of the Study
2.3 List of Assumptions
2.4 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Rising hospital-acquired infections (HAI)
4.2.2 Increasing surgical procedures and surgical site infections
4.2.3 Rising geriatric population
4.3 Restraints
4.3.1 Side-effects of CHG
4.3.2 Product recalls
4.4 Opportunity
4.4.1 Entering Developing Economies
5 Market Factor Analysis
5.1 Porter's Five Forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.2.1 Research & Development
5.2.2 Manufacturing
5.2.3 Distribution
5.2.4 Marketing & Sales
5.2.5 Post-Sales Monitoring
6 Global Chlorhexidine Gluconate (CHG) Wipes Market, by Product Type
6.1 Introduction
6.2 CHG Bath Wipes
6.3 CHG/Alcohol-Based Wipes
7 Global Chlorhexidine Gluconate (CHG) Wipes Market, by Concentration
7.1 Introduction
7.2 2%
7.3 0.50%
8 Global Chlorhexidine Gluconate (CHG) Wipes Market, by Application
8.1 Introduction
8.2 Surgical Site Infection
8.3 Central Line-Associated Bloodstream Infection
8.4 Catheter-Associated Urinary Tract Infections
8.5 Lens Cleaners
9 Global Chlorhexidine Gluconate (CHG) Wipes Market, by Distribution Channel
9.1 Introduction
9.2 Hospital & Retail Pharmacies
9.3 Online Platforms
10 Global Chlorhexidine Gluconate (CHG) Wipes Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 US
10.2.1.1 Canada
10.2.2 Latin America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 UK
10.3.1.3 France
10.3.1.4 Italy
10.3.1.5 Spain
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Middle East & Africa
10.5.1 Middle East
10.5.2 Africa
11 Competitive landscape
11.1 Introduction
11.2 Key developments
12 Company Profile
12.1 3M
12.1.1 Company Overview
12.1.2 Financial Overview
12.1.3 Products/Services Offered
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.1.6 Key Strategies
12.2 Cardinal Health
12.2.1 Company Overview
12.2.2 Financial Overview
12.2.3 Products/Services Offered
12.2.4 SWOT Analysis
12.2.5 Key Developments
12.2.6 Key Strategies
12.3 Carenow Medical Pvt. Ltd
12.3.1 Company Overview
12.3.2 Financial Overview
12.3.3 Products/Services Offered
12.3.4 Key Developments
12.3.5 SWOT Analysis
12.3.6 Key Strategy
12.4 PDI Limited
12.4.1 Company Overview
12.4.2 Financial Overview
12.4.3 Products/Services Offered
12.4.5 SWOT Analysis
12.4.6 Key Strategies
12.5 GAMA Healthcare Ltd.
12.5.1 Company Overview
12.5.2 Financial Overview
12.5.3 Products/Services Offered
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.5.6 Key Strategies
12.6 Lernapharm Inc.
12.6.1 Company Overview
12.6.2 Financial Overview
12.6.3 Products/Services Offered
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.6.6 Key Strategies
12.7 Pal International
12.7.1 Company Overview
12.7.3 Products/Services Offered
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.7.6 Key Strategies
12.8 Becton, Dickinson and Company
12.8.1 Company Overview
12.8.2 Financial Overview
12.8.3 Products/Services Offered
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.8.6 Key Strategies
12.9 Optimum Medical Limited
12.9.1 Company Overview
12.9.2 Financial Overview
12.9.3 Products/Services Offered
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.9.6 Key Strategies
13 Appendix
13.1 Discussion Blueprint
13.2 References